Alzheimer's Drug Discovery Foundation
alzdiscovery.org Direct investor
The Alzheimer's Drug Discovery Foundation is a not-for-profit venture philanthropy that makes investments, not grants, in Alzheimer's drug development, biomarker and prevention research in academia and the biotech industry. It uses all returns to support its charitable mission.
Alzheimer's Drug Discovery Foundation is an investor headquartered in New York, United States, founded in 1998. It invests directly in companies, in Alzheimer's disease, drug development, biomarkers and prevention. 792 portfolio companies, as it reports.
“The ADDF focuses on translating the knowledge we have gained about the causes of Alzheimer's disease – known as the "biology of aging" – into drugs to conquer it.”
— Alzheimer's Drug Discovery Foundation, own website
- Layer
- Direct investor
- Type
- Other
- Stage
- Not stated
- Headquarters
- New York, United States
- Invests in
- global
- Sectors
- Alzheimer's disease, drug development, biomarkers, prevention
- Founded
- 1998
- Portfolio
- 792 companies
- How to reach it
- Its contact page on its own site
Team, as Alzheimer's Drug Discovery Foundation publishes it
- Isobel Coleman Chief Executive Officer
- Karen Harris Executive Director, Mission Related Investments and Finance
- Jane McIntosh Chief Philanthropy and External Affairs Officer
- Laura Nisenbaum, PhD Interim Chief Science Officer
- Aaron Burstein, PharmD Head, Search and Evaluation
- Tyler Demarest, PhD Director, Search and Evaluation
- Marisa Goo, PhD Assistant Director, Search and Evaluation
- Yuko Hara, PhD Director, Aging and Alzheimer's Prevention
- Melissa Lee, PhD Director, Diagnostics Accelerator, Digital & AI
- Marina D'Emic Chief Financial Officer
- Howard Fillit, MD Co-Founder and Chief Science Officer Emeritus
- Ronald S. Lauder Chairman and Co-Founder
Names and roles exactly as listed on alzdiscovery.org. Nothing else about these people is recorded.
Named by events
Each event below names or links Alzheimer's Drug Discovery Foundation on its own website — as the firm of a speaker, a partner or a listed investor. The event is the source, not the investor; it says nothing about who will be in the room.
- BIO International Convention 2027 Philadelphia, United States · named on its investors page
Where this comes from
Every fact above was read from a page Alzheimer's Drug Discovery Foundation publishes itself. Nothing is taken from third-party databases. Investment activity (deals, co-investors) is not yet recorded.
- https://www.alzdiscovery.org/name, is_investor, hq_country, hq_city, status, approach_url
- https://www.alzdiscovery.org/about-addflayer, type, invests_in_geographies, sectors, thesis_quote, description, founded, portfolio_count, confidence
- https://www.alzdiscovery.org/about-addf/staffpeople
- https://www.alzdiscovery.org/about-addf/our-founderspeople
Record 22128 · added 2026-11-17 · link last verified 2026-11-17 · confidence high
Similar investors
- 325 CapitalOther · Not applicable · New York, United States
- 3i FundOther · Growth · New York, United States
- A4 PartnersOther · Growth · New York, United States
- Abinger Partners LLCOther · Not applicable · New York, United States
- Access Capital, Inc.Other · Growth – Buyout · New York, United States
- Alkeon Capital Management, LLCOther · New York, United States